Mural Oncology PLC (MURA)
3.74
-0.15
(-3.86%)
USD |
NASDAQ |
May 17, 16:00
3.74
0.00 (0.00%)
Pre-Market: 20:00
Mural Oncology Cash from Financing (TTM): 412.68M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 412.68M |
| Date | Value |
|---|---|
| December 31, 2023 | 468.81M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
412.68M
Minimum
Mar 2024
468.81M
Maximum
Dec 2023
440.74M
Average
440.74M
Median
Cash from Financing (TTM) Benchmarks
| Amarin Corp PLC | -1.56M |
| Jazz Pharmaceuticals PLC | -332.02M |
| Prothena Corp PLC | 22.66M |
| Iterum Therapeutics PLC | 8.016M |
| GH Research PLC | -0.205M |